Chief Science Officer, U.S. Urology Partners, Clinical Assistant Professor, Department of Urology, Vanderbilt School of Medicine
BIOGRAPHY
Speaker
Abstract
Over the past 10 years, we have come to a greater understanding of the pathogenesis of men who succumb to prostate cancer. One critical aspect is the role of molecular drivers in patients with higher grade disease and the implications in management for both localized and advanced prostate cancer. In order to best manage these patients, the provider needs a basic comprehension of the role and rationale of genetic testing, how to best categorize the various genes involved in prostate cancer development and incorporate this into their practice. This presentation will give the provider a foundation to simplify the complexity and understanding of genomic testing and the role of the urologist.
Learning Objectives:
1. Differentiate Germline vs Somatic Testing.
2. Categorize the genes associated with different DNA repair pathways.
3. Review the different types of genetic mutations and classifications.
You May Also Like
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
MAY 15, 2024 | 10:00 AM
Join this year's poster presenters in the Poster Hall during the Poster Networking Hour, Wednesday, September 6th, from 1:00 –2:00 PM PDT , to chat live about their posters and lat...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...